TECH
Bio-Techne insider trading
Health Care · Net selling
Close · Oct 5, 2026
$72.58
+17.9% over 12 months
Share price and insider trades
TECH closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$437K
Insiders buying0
Insiders selling1
Valuation, profit and volume
P/E (trailing)n/aSector median 24.5
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day0.8×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 Bio-Techne insiders reported open-market purchases totaling $0, while 1 insider reported sales totaling $437K. 0 of 2 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 59 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| May 12SEC | Amy E. HerrDirector | Sell | 6,636 | $48.28 | $320K | +50.3% | — |
| Feb 19SEC | Amy E. HerrDirector | Sell | 1,976 | $59.10 | $117K | +22.8% | — |
Insiders at Bio-Techne
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Amy E. HerrDirector | — | $437K | Aug 18, 2026 | — |
| John L HigginsDirector | — | — | Sep 30, 2026 | — |
| Robert V BaumgartnerDirector | — | — | Sep 24, 2026 | — |
| Kim KeldermanCEO | — | — | Aug 18, 2026 | — |
| James HippelCFO | — | — | Aug 18, 2026 | — |
| William GeistPresident | — | — | Aug 18, 2026 | — |
| Steven C. CrousePresident | — | — | Aug 18, 2026 | — |
| Shane BohnenGeneral Counsel | — | — | Aug 18, 2026 | — |
| Matthew McmanusPresident | — | — | Feb 3, 2026 | — |
| Rupert VesseyDirector | — | — | Nov 3, 2025 | — |
| Judith V. KlimovskyDirector | — | — | Nov 3, 2025 | — |
| Alpna SethDirector | — | — | Nov 3, 2025 | — |
| Joseph D KeeganDirector | — | — | Nov 3, 2025 | — |
| Julie L BushmanDirector | — | — | Nov 3, 2025 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about TECH insiders
Are Bio-Techne insiders buying TECH stock?
In the past 12 months, 0 insiders reported open-market purchases of TECH worth $0.
Are Bio-Techne insiders selling TECH stock?
1 insiders reported sales worth $437K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.